---
title: "Psych News Alert: APA Publishes Practice Guideline on Antipsychotic Use in Patients with Dementia"
description: APA this week released the Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia —a s...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/appi_books_9780890426807_cover-Jun-24-2025-03-28-07-4055-PM.jpg
---

 5/5/16 12:00 AM

# APA Publishes Practice Guideline on Antipsychotic Use in Patients with Dementia

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/appi_books_9780890426807_cover-Jun-24-2025-03-28-06-1321-PM.jpg?width=153&height=200&name=appi_books_9780890426807_cover-Jun-24-2025-03-28-06-1321-PM.jpg) |  |
| --- | --- |

APA this week released the [Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia](http://psychiatryonline.org/doi/book/10.1176/appi.books.9780890426807)—a set of 15 evidence-based recommendations for how best to approach this critical pharmacological challenge.

Studies show that agitation and psychosis are among the leading risk factors for institutionalization and death in patients with dementia.

“Any antipsychotic might be useful for managing dementia-related psychosis or agitation in certain circumstances,” said Victor Reus, M.D., a professor of psychiatry at the University of California, San Francisco, and chair of the 10-member group that developed the guidelines. “The concern in the field at large has been that when people receive a prescription, it’s never changed and it continues on indefinitely, which over time carries increasing risks of morbidity and even mortality. The problem is that many patients are never reassessed,” he told *Psychiatric News*.

The guideline includes recommendations on assessing the psychological and behavioral symptoms of dementia; the risks and benefits of antipsychotic use; and specifics for dosing, duration, and monitoring of antipsychotic therapy to ensure thoughtful and judicious use. Additionally, the guideline emphasizes the importance of developing a comprehensive treatment plan that includes appropriate person-centered psychosocial and pharmacological treatments.

“We feel these evidence-based recommendations, with the extensive review and broad input supporting them, provide a valuable resource for clinicians, individuals, caregivers, and others,” APA President Renée Binder, M.D., wrote in her latest [blog post](http://psychiatry.org/news-room/apa-blogs/apa-blog/2016/05/new-apa-guidelines-limit-use-of-antipsychotics-for-agitation-and-psychosis-in-patients-with-dementia). “The guidelines will help promote the best decisions possible for patients with dementia and symptoms of agitation and psychosis and will contribute to improving care for many older adults.”

An [executive summary](http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2015.173501) of the guidelines appears in the May issue of the *American Journal of Psychiatry*.

A complete list of APA’s Practice Guidelines can be found on [PsychiatryOnline](http://psychiatryonline.org/guidelines).

[psychosis](https://alert.psychnews.org/tag/psychosis), [antipsychotics](https://alert.psychnews.org/tag/antipsychotics), [agitation](https://alert.psychnews.org/tag/agitation), [dementia](https://alert.psychnews.org/tag/dementia), [Practice Guidelines](https://alert.psychnews.org/tag/practice-guidelines)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/hands_hospital_iStock-175226565-Jun-24-2025-07-22-33-3345-PM.jpg?height=200&name=hands_hospital_iStock-175226565-Jun-24-2025-07-22-33-3345-PM.jpg) ](https://alert.psychnews.org/2019/09/risks-of-antipsychotics-for-treatment.html)

[olanzapine](https://alert.psychnews.org/tag/olanzapine), [risperidone](https://alert.psychnews.org/tag/risperidone), [quetiapine](https://alert.psychnews.org/tag/quetiapine), [hospital length of stay](https://alert.psychnews.org/tag/hospital-length-of-stay), [antipsychotics](https://alert.psychnews.org/tag/antipsychotics), [delirium](https://alert.psychnews.org/tag/delirium), [mortality](https://alert.psychnews.org/tag/mortality), [hospitalized patients](https://alert.psychnews.org/tag/hospitalized-patients), [haloperidol](https://alert.psychnews.org/tag/haloperidol)

## [Risks of Antipsychotics for Treatment of Delirium May Outweigh Benefits, Review Finds](https://alert.psychnews.org/2019/09/risks-of-antipsychotics-for-treatment.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/6/19 12:00 AM

There may be no benefits to treating hospitalized patients experiencing delirium with...

[ Read more ](https://alert.psychnews.org/2019/09/risks-of-antipsychotics-for-treatment.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/FDA_NewLogo_1-Jun-24-2025-04-27-37-9552-PM.jpg?height=200&name=FDA_NewLogo_1-Jun-24-2025-04-27-37-9552-PM.jpg) ](https://alert.psychnews.org/2023/05/fda-approves-brexpiprazole-for.html)

[schizophrenia](https://alert.psychnews.org/tag/schizophrenia), [Alzheimer's disease](https://alert.psychnews.org/tag/alzheimers-disease), [major depressive disorder](https://alert.psychnews.org/tag/major-depressive-disorder), [FDA](https://alert.psychnews.org/tag/fda), [agitation](https://alert.psychnews.org/tag/agitation), [dementia](https://alert.psychnews.org/tag/dementia), [Food and Drug Administration](https://alert.psychnews.org/tag/food-and-drug-administration), [brexpiprazole](https://alert.psychnews.org/tag/brexpiprazole), [Rexulti](https://alert.psychnews.org/tag/rexulti)

## [FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease](https://alert.psychnews.org/2023/05/fda-approves-brexpiprazole-for.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 5/11/23 12:00 AM

The U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti...

[ Read more ](https://alert.psychnews.org/2023/05/fda-approves-brexpiprazole-for.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/therapist_patient_iStock-1058833158-Jun-24-2025-04-35-20-3217-PM.jpg?height=200&name=therapist_patient_iStock-1058833158-Jun-24-2025-04-35-20-3217-PM.jpg) ](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

[clozapine](https://alert.psychnews.org/tag/clozapine), [psychosocial interventions](https://alert.psychnews.org/tag/psychosocial-interventions), [patient preference](https://alert.psychnews.org/tag/patient-preference), [Institute of Medicine](https://alert.psychnews.org/tag/institute-of-medicine), [evaluation](https://alert.psychnews.org/tag/evaluation), [pharmacotherapy](https://alert.psychnews.org/tag/pharmacotherapy), [APA Practice Guideline for the Treatment of Patien](https://alert.psychnews.org/tag/apa-practice-guideline-for-the-treatment-of-patien)

## [APA Releases Updated Practice Guideline for Treatment of Patients With Schizophrenia](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/2/20 12:00 AM

Yesterday, APA released a new evidence-based guideline on treating patients with schizophrenia. The...

[ Read more ](https://alert.psychnews.org/2020/09/apa-releases-updated-practice-guideline.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T15:31:35.601Z",
  "datePublished" : "2016-05-05T04:00:00.000Z",
  "headline" : "Psych News Alert: APA Publishes Practice Guideline on Antipsychotic Use in Patients with Dementia",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/appi_books_9780890426807_cover-Jun-24-2025-03-28-07-4055-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2016/05/apa-publishes-practice-guideline-on.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```